- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02227472
Working Memory and School Readiness in Preschool-Aged Children With Sickle Cell Disease
Working Memory and School Readiness in Preschool-Aged Children With Sickle Cell Disease: Family and Environmental Factors
Children with sickle cell disease (SCD) are at risk for neurobehavioral problems because of the impact the disease can have on the central nervous system. Specific impairments in working memory are particularly prevalent in school-aged children with SCD. Working memory is more strongly associated with school readiness and academic success than intellectual ability in the general population. The adverse effects of low socioeconomic status (SES) and poverty on cognition and neurodevelopment emerge early, before children have entered formal education. In addition, they affect language and executive function skills (e.g., working memory) more than other skills. SES is a proxy variable for other risk factors. Higher SES is associated with less parental stress, more supportive parenting practices, and better cognitive stimulation based on the availability of books, computers, and outings.
PRIMARY OBJECTIVE:
- To examine working memory and school readiness in young children with sickle cell disease in comparison to demographically matched control children without sickle cell disease.
SECONDARY OBJECTIVE:
- To examine the relationships of family/environmental factors (caregiver stress, parental responsiveness, and cognitive stimulation in the home) and disease severity to working memory and school readiness skills in preschool-aged children with SCD.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Participants will be recruited through the Pediatric Sickle Cell Clinic at St. Jude. All participants with SCD will be evaluated once with laboratory measures of cognitive and pre-academic skills and parent questionnaires. Medical history will be evaluated for purposes of characterizing the health status and disease severity of patients and determining how medical factors are related to school readiness and working memory in SCD population. The study expects to accrue up to 99 participants with SCD.
Demographically-matched control children will be selected from a database of participants enrolled in an ongoing longitudinal study of neurocognitive development in children born in Shelby County, Tennessee. The control group will be randomly selected from an existing study group and will not be enrolled on the MEMREAD protocol. Control group participants will be excluded if they have any sensory or motor impairment that would preclude valid testing (e.g., blindness, paresis), or if they have received treatment with non-stimulant psychotropic medication. A de-identified data file that includes the following results for up to 168 demographically-matched healthy control participants (approximately 1:2 ratio of SCD to healthy control) will be provided for control comparison purposes:
- Health Evaluation (CV4)
- Stanford binet - Fifth Edition (CV4)
- Bracken Basic Concepts Scale - Third Edition (CV4)
- The Behavior Rating Inventory of Executive Function - Preschool Version (BRIEF-P) (CV4)
- The Scales of Independent Behavior - Revised, Early Development Form (SIB-R) (CV4)
- Demographics (CV4)
- Additional Covariates (if any) including gestational age at birth, developmental delays, major medical illnesses, surgery history, neurological event history, pre-kindergarten attendance, and daycare attendance
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Tennessee
-
Memphis, Tennessee, United States, 38105
- St. Jude Children's Research Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patient at St. Jude Children's Research Hospital (SJCRH) with a primary diagnosis of sickle cell disease
- 48-68 months of age at time of enrollment
- English as primary language
Exclusion Criteria:
- Sensory or motor impairment that would preclude valid testing (e.g., blindness, paresis)
- Treatment with non-stimulant psychotropic medication
- Enrollment in kindergarten at time of assessment
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Sickle Cell Disease
All participants who meet eligibility requirements and consent to the study will complete evaluation of cognitive and pre-academic skills, and parent questionnaires.
|
Participants will complete testing to evaluate fluid reasoning, knowledge, quantitative reasoning, visual-spatial processing, verbal and non-verbal working memory, and knowledge of pre-academic skills (such as colors, letters, numbers, counting, sizes, comparisons, and shapes).
Other Names:
Parents will complete questionnaires to assess behavioral manifestation of executive functions, functional independence and adaptive functioning, child and parent characteristics, situational/demographic life stress, demographics, education level, and household income.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mean difference in working memory between SCD participants and control group
Time Frame: Once, at enrollment
|
Variables will be subjected to analyses to establish frequency distributions, means and standard deviations, and to determine if variables are normally distributed prior to use of parametric statistics.
The primary dependent variable for working memory ability is the Working Memory Index from the SB-5.
Primary dependent variables will be compared statistically using a paired sample one-side t-test.
|
Once, at enrollment
|
|
Mean difference in school readiness between SCD group and control group
Time Frame: Once, at enrollment
|
Variables will be subjected to analyses to establish frequency distributions, means and standard deviations, and to determine if variables are normally distributed prior to use of parametric statistics.
The primary dependent variable for school readiness is the School Readiness Composite from the BBCS.
Primary dependent variables will be compared statistically using a paired sample one-side t-test.
|
Once, at enrollment
|
|
Association between working memory and school readiness skills compared between SCD group and control group
Time Frame: Once, at enrollment
|
Variables will be subjected to analyses to establish frequency distributions, means and standard deviations, and to determine if variables are normally distributed prior to use of parametric statistics.
Bivariate correlations will be used to investigate the association between working memory and school readiness skills.
|
Once, at enrollment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Effect of family/environmental factors and disease severity on measures of working memory
Time Frame: Once, within 6 months of enrollment
|
Regression analyses will be used to examine the main effects of each family/environmental factor (caregiver stress, parental responsiveness, and cognitive stimulation in the home) and disease severity factors on measures of working memory and school readiness.
|
Once, within 6 months of enrollment
|
|
Effect of family/environmental factors and disease severity on school readiness
Time Frame: Once, within 6 months of enrollment
|
Regression analyses will be used to examine the main effects of each family/environmental factor (caregiver stress, parental responsiveness, and cognitive stimulation in the home) and disease severity factors on measures of working memory and school readiness.
|
Once, within 6 months of enrollment
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MEMREAD
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sickle Cell Disease
-
Connecticut Children's Medical CenterChildren's Hospital of Philadelphia; National Heart, Lung, and Blood Institute... and other collaboratorsNot yet recruitingSickle Cell Disease | Sickle Cell Disease (SCD) | Sickle Cell Anemia in Children | Sickle Cell | Sickle Cell Anemia (HbSS)United States
-
Klein Buendel, Inc.National Institute on Minority Health and Health Disparities (NIMHD); Hilton...CompletedSickle Cell Disease | Sickle Cell Anemia in Children | Sickle Cell Thalassemia | Sickle Cell SC DiseaseUnited States
-
Nova Laboratories LimitedCompletedSickle Cell Disease | Sickle Cell Hemoglobin C | Sickle Cell-beta-thalassemia | Sickle-Cell; Hemoglobin Disease, ThalassemiaUnited Kingdom, Jamaica
-
Academisch Medisch Centrum - Universiteit van Amsterdam...CompletedSickle Cell Disease | Sickle Cell SC Disease | Sickle Cell-SS Disease | Sickle Cell RetinopathyNetherlands
-
SangartWithdrawnSickle Cell Disease | Anemia, Sickle Cell | Sickle Cell Anemia | Hemoglobin SC Disease | Sickle Cell Disorders | Sickle Cell Hemoglobin C DiseaseFrance, United Kingdom, Netherlands, Turkey, Bahrain, Belgium, Brazil, Lebanon, Qatar
-
SangartCompletedSickle Cell Disease | Anemia, Sickle Cell | Sickle Cell Anemia | Hemoglobin SC Disease | Sickle Cell Disorders | Sickle Cell Hemoglobin C DiseaseUnited Kingdom, France, Jamaica, Lebanon
-
University of British ColumbiaCompletedSickle Cell Disease | Beta-Thalassemia | Sickle Cell Trait | Sickle Cell-Beta Thalassemia | Sickle Cell-SS DiseaseCanada, Nepal
-
Sidney Kimmel Cancer Center at Thomas Jefferson...National Heart, Lung, and Blood Institute (NHLBI)TerminatedSickle Cell Anemia | Sickle Cell-hemoglobin C Disease | Sickle Cell-β0-thalassemiaUnited States
-
University of RegensburgRecruitingSickle Cell Disease | Sickle Cell Anemia | Sickle Cell Disorders | HbS Disease | Hemoglobin S Disease | Sickling Disorder Due to Hemoglobin SGermany, Austria
-
Centre Hospitalier Intercommunal CreteilRecruitingSickle-Cell Disease Nos With CrisisFrance
Clinical Trials on Evaluation of cognitive and pre-academic skills
-
NYU Langone HealthNational Institute of Mental Health (NIMH)CompletedSocial Anxiety DisorderUnited States
-
Hospices Civils de LyonCompleted
-
Fenway Community HealthNational Institute of Mental Health (NIMH)CompletedRisk ReductionUnited States
-
IRCCS Fondazione Stella MarisUniversity of Pisa; University of Florence; Anastasis Società Cooperativa SocialeNot yet recruitingExecutive Functions in Cerebral PalsyItaly
-
Korea UniversityNational Research Foundation of KoreaActive, not recruiting
-
Stanford UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingCognitive Dysfunction | Cognitive Change | Learning Disabilities | Individuality | Child Development | Developmental Disability | Behavior | Cognition | Learning Curve | Decision Making | Behavior and Behavior Mechanisms | Behavior, Child | Cognitive Impairment, Mild | Cognition Disorder | Neuroscience | Cognitive Orientation and other conditionsUnited States
-
Univ.-Doz. Dr.med.univ. Gernot Hudelist, MSc.RecruitingEndometriosis, RectumAustria
-
Northwestern UniversityHarvard UniversityActive, not recruitingStress, Psychological | Stress, Emotional | Stress, PhysiologicalUnited States
-
University Hospital, ToulouseCompleted